Met-Lys-Bradykinin is a modified bradykinin analog incorporating methionine and lysine to alter receptor selectivity. Its sequence supports probing steric and electrostatic influences on kinin signaling. Researchers apply it to map structural determinants of receptor-binding bias. The peptide aids kinin-pathway structural investigations.
CAT No: B09018
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More